Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yifei Cheng

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Pediatric Transplantation|September 28, 2020
Unmanipulated haploidentical hematopoietic stem cell transplantation for children with myelodysplastic syndromePan Suo, Shasha Wang, Yujuan Xue, et al.
Frontiers in Immunology|February 16, 2026
Multi-omics analyses related to unfolded protein response in prostate cancer implicate pro-tumor role of IFRD1Yifeng Xue, Enyao Huang, Caichen Luo, et al.
International Journal of Laboratory Hematology|October 4, 2022
Effects of CD34<sup>+</sup> cell dose on haematopoietic recovery in acute lymphoblastic leukaemia patients with positive pretransplant measurable residual diseaseYuewen Wang, Xiaodong Mo, Yifei Cheng, et al.
Transplantation and Cellular Therapy|March 22, 2026
Survival advantage of reduced-toxicity conditioning in haploidentical hematopoietic cell transplantation for severe aplastic anemia patients with pre-transplant comorbiditiesFan Lin, Zhengli Xu, Tingting Han, et al.
Chinese Medical Journal|August 28, 2023
Comparison of clinical features of nephrotic syndrome after haploidentical and matched donor hematopoietic stem cell transplantationWei Sun, Yuanyuan Zhang, Yuhong Chen, et al.
Clinical Transplantation|October 16, 2021
A modified conditioning regimen based on low-dose cyclophosphamide and fludarabine for haploidentical hematopoietic stem cell transplant in severe aplastic anemia patients at risk of severe cardiotoxicityFan Lin, Yuanyuan Zhang, Tingting Han, et al.
Nature Communications|April 8, 2024
Integration of pathologic characteristics, genetic risk and lifestyle exposure for colorectal cancer survival assessmentJunyi Xin, Dongying Gu, Shuwei Li, et al.
Annals of Hematology|July 12, 2023
Time-dependent analysis of the impact on early cytomegalovirus reactivation of HLA mismatch and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation from related donors in acquired aplastic anemiaFan Lin, Xinyu Dong, Yuanyuan Zhang, et al.
Annals of Hematology|June 23, 2022
Comparable clinical outcomes of haploidentical hematopoietic stem cell transplantation in patients with hepatitis-associated aplastic anemia and non-hepatitis-associated aplastic anemiaXiaodi Ma, Yangyang Zuo, Zhengli Xu, et al.
Annals of Hematology|February 21, 2024
Clinical characteristics and outcomes of allogeneic hematopoietic stem cell transplantation recipients with coronavirus disease 2019 caused by the Omicron variant: a prospective, observational cohort studyShuang Fan, Xiaodong Mo, Xiaohui Zhang, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Pediatric Transplantation|September 28, 2020
Unmanipulated haploidentical hematopoietic stem cell transplantation for children with myelodysplastic syndromePan Suo, Shasha Wang, Yujuan Xue, et al.
Frontiers in Immunology|February 16, 2026
Multi-omics analyses related to unfolded protein response in prostate cancer implicate pro-tumor role of IFRD1Yifeng Xue, Enyao Huang, Caichen Luo, et al.
International Journal of Laboratory Hematology|October 4, 2022
Effects of CD34<sup>+</sup> cell dose on haematopoietic recovery in acute lymphoblastic leukaemia patients with positive pretransplant measurable residual diseaseYuewen Wang, Xiaodong Mo, Yifei Cheng, et al.
Transplantation and Cellular Therapy|March 22, 2026
Survival advantage of reduced-toxicity conditioning in haploidentical hematopoietic cell transplantation for severe aplastic anemia patients with pre-transplant comorbiditiesFan Lin, Zhengli Xu, Tingting Han, et al.
Chinese Medical Journal|August 28, 2023
Comparison of clinical features of nephrotic syndrome after haploidentical and matched donor hematopoietic stem cell transplantationWei Sun, Yuanyuan Zhang, Yuhong Chen, et al.
Clinical Transplantation|October 16, 2021
A modified conditioning regimen based on low-dose cyclophosphamide and fludarabine for haploidentical hematopoietic stem cell transplant in severe aplastic anemia patients at risk of severe cardiotoxicityFan Lin, Yuanyuan Zhang, Tingting Han, et al.
Nature Communications|April 8, 2024
Integration of pathologic characteristics, genetic risk and lifestyle exposure for colorectal cancer survival assessmentJunyi Xin, Dongying Gu, Shuwei Li, et al.
Annals of Hematology|July 12, 2023
Time-dependent analysis of the impact on early cytomegalovirus reactivation of HLA mismatch and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation from related donors in acquired aplastic anemiaFan Lin, Xinyu Dong, Yuanyuan Zhang, et al.
Annals of Hematology|June 23, 2022
Comparable clinical outcomes of haploidentical hematopoietic stem cell transplantation in patients with hepatitis-associated aplastic anemia and non-hepatitis-associated aplastic anemiaXiaodi Ma, Yangyang Zuo, Zhengli Xu, et al.
Annals of Hematology|February 21, 2024
Clinical characteristics and outcomes of allogeneic hematopoietic stem cell transplantation recipients with coronavirus disease 2019 caused by the Omicron variant: a prospective, observational cohort studyShuang Fan, Xiaodong Mo, Xiaohui Zhang, et al.
Pageof 11